61559-82-8

Basic information

• Product Name: 1,2-Benzenediol, 3-bromo-6-methoxy-
• CAS NO: 61559-82-8
• Molecular Formula: C7H7BrO3
• Molecular Weight: 219.035
• Mol File: 61559-82-8.mol
• Article Data: 12

Chemical Properties

• CAS DataBase Reference: 1,2-Benzenediol, 3-bromo-6-methoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2-Benzenediol, 3-bromo-6-methoxy-(61559-82-8)
• EPA Substance Registry System: 1,2-Benzenediol, 3-bromo-6-methoxy-(61559-82-8)

Safety Data

• Hazardous Substances Data: 61559-82-8(Hazardous Substances Data)

Usage

General Description

1,2-Benzenediol, 3-bromo-6-methoxy- is a chemical compound that belongs to the category of benzenediols. It is also known as 3-bromo-6-methoxy-catechol. 1,2-Benzenediol, 3-bromo-6-methoxy- is a derivative of catechol, with a bromine atom and a methoxy group attached to the benzene ring. It is commonly used in organic synthesis and pharmaceutical research due to its potential pharmacological properties. 1,2-Benzenediol, 3-bromo-6-methoxy- has also been studied for its antioxidant and anti-inflammatory activities, making it of interest in the development of new drugs and treatments. Additionally, it may have applications in biochemical research and as a building block in the synthesis of other organic compounds.

Upstream product

• 20035-41-0 6-bromo-2-hydroxy-3-methoxybenzaldehyde 
• 934-00-9 3-methocycatechol 
• 159263-87-3 2-acetyloxy-3-methoxy-6-bromobenzaldehyde 
• 148-53-8 3-methoxy-2-hydroxybenzaldehyde 
• 7150-01-8 2-acetoxy-3-methoxybenzaldehyde 
• 37942-01-1 5-bromo-2-methoxyphenol 
• 104-92-7 1-bromo-4-methoxy-benzene 

Downstream Products

• 61535-22-6 1-bromo-4-methoxy-2,3-methylenedioxybenzene 
• 203259-23-8 2,3-dibenzyloxy-4-methoxy-1-bromobenzene 
• 290347-52-3 (2',3'-dihydroxy-4'-methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone 
• 290347-54-5 2',3'-bis(methoxymethyloxy)-3,4,4',5-tetramethoxydiphenylcarbinol 
• 290347-63-6 2',3'-Bis(methoxymethyloxy)-3,4,4',5-tetramethoxybenzophenone 
• 290347-55-6 phosphoric acid dibenzyl ester 2-(bis-benzyloxy-phosphoryloxy)-6-methoxy-3-(3,4,5-trimethoxy-benzoyl)-phenyl ester 
• 1622437-83-5 2-benzoyl-4-(5,8-dimethoxy-2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1-phenylbutane-1,4-dione 
• 1622430-95-8 1-(5,8-dihydroxy-2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-phenylpropane-1,3-dione 
• 1622430-94-7 1-(5,8-dimethoxy-2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-phenylpropane-1,3-dione 
• 1345880-60-5 2-(2-(cyclopropylmethoxy)-3-methoxy-6-(1-oxo-1,3-dihydroisobenzofuran-5-yl)phenoxy)-N-propylacetamide 
• 1345882-32-7 2-(2-(cyclopropylmethoxy)-3-methoxy-6-(1-oxo-1,3-dihydroisobenzofuran-5-yl)phenoxy)acetic acid 
• 1345882-31-6 ethyl 2-(2-(cyclopropylmethoxy)-3-methoxy-6-(1-oxo-1,3-dihydroisobenzofuran-5-yl)phenoxy)acetate 
• 1345880-59-2 5-(3-cyclopropylmethoxy-2-(4-methanesulfonylbenzyloxy)-4-methoxyphenyl)-3H-isobenzofuran-1-one 
• 1345880-58-1 5-(3-cyclopropylmethoxy-4-methoxy-2-(3-methoxymethyloxetan-3-ylmethoxy)phenyl)-3H-isobenzofuran-1-one 

Relevant articles and documents

GAMMA-DIKETONES AS WNT/BETA -CATENIN SIGNALING PATHWAY ACTIVATORS

The present disclosure provides γ-diketones or analogs thereof, that activate Wnt/β-catenin signaling and thus treat or prevent diseases related to signal transduction, such as osteoporosis and osteoarthropathy; osteogenesis imperfecta, bone defects, bone fractures, periodontal disease, otosclerosis, wound healing, craniofacial defects, oncolytic bone disease, traumatic brain injuries or spine injuries, brain atrophy/neurological disorders related to the differentiation and development of the central nervous system, including Parkinson's disease, strokes, ischemic cerebral disease, epilepsy, Alzheimer's disease, depression, bipolar disorder, schizophrenia; otic disorders like cochlear hair cell loss; eye diseases such as age related macular degeneration, diabetic macular edema or retinitis pigmentosa and diseases related to differentiation and growth of stem cell, such as hair loss, hematopoiesis related diseases and tissue regeneration related diseases.

BIARYL PHOSPHODIESTERASE 1NHIBITORS

Novel biaryl compounds with phosphodiesterase inhibitory activity of the general formula (I), wherein R1, R2, R3, X, Y, Z1, Z2, Z3, and Z4 have the meanings defined herein, as well as their use as therapeutic agents in the treatment of inflammatory diseases and conditions

Combretastatin analogs with tubulin binding activity

Analogs of combretastatin have been discovered which demonstrate impressive cytotoxicity as well as a remarkable ability to inhibit tubulin polymerization. Such compounds are excellent clinical candidates for the treatment of cancer in humans. In addition, certain of these ligands, as pro-drugs, may well prove to be tumor selective vascular targeting chemotherapeutic agents or to have vascular targeting activity resulting in the selective prevention and/or destruction of nonmalignant proliferating vasculature.